netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Chapter
Notes:

Please also refer to the Cancer Drugs Fund list

Where a formulary entry does not detail a medicine’s indications for use, the medicine can be assumed to be approved for all licensed indications.

Formulary approved "off-label" use is detailed separately.

 Details...
08.04  Expand sub section  Miscellaneous preparations
 note 
Gliolan powder for oral solution
View SPC online
Formulary
Red

 

 
   
Acid citrate glucose infusion
Unlicensed Drug Unlicensed
Red

Anticoagulant used during apheresis

 
   
Cold storage solution
Unlicensed Drug Unlicensed
Red
Perfusion solution for liver grafts from Non Heart Beating Donors 
   
Indocyanine green (ICG) dye
Unlicensed Drug Unlicensed
Red
Added to 9mTc nanocolloid to improve detection of sentinel nodes. 50 microlitres of 5 mg/mL injected at tumour site, 2 hours before surgery 
   
Intrinsic factor caps
Unlicensed Drug Unlicensed
Red
Part 2 of Schilling test for vitamin B12 deficiency 
   
Muromonab-CD3 injection (monoclonal (OKT3))
Unlicensed Drug Unlicensed
Red
Liver and renal graft rejection 
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   

Amber 1

Treatment can be initiated in primary care after a recommendation from an appropriate specialist  

Amber 2

Specialist initiation followed by maintenance prescribing in primary care  

Amber 3

Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  

Green

Specialist and non-specialist initiation  

Grey

Not recommended for prescribing  

netFormulary